62-year-old man with history of oropharyngeal cancer, treated by chemoradiation therapy. Contrast-enhanced multiphase DECT of chest performed for surgical planning. Axial image from iodine concentration map, reconstructed from equilibrium-phase acquisition, shows thin ringlike peripheral high iodine concentration, involving nodule’s entire circumference. Nodule underwent resection, revealing oropharyngeal carcinoma metastasis. Case represents true-positive example of using ringlike peripheral high iodine co

62-year-old man with history of oropharyngeal cancer, treated by chemoradiation therapy. Contrast-enhanced multiphase DECT of chest performed for surgical planning. Axial image from iodine concentration map, reconstructed from equilibrium-phase acquisition, shows thin ringlike peripheral high iodine concentration, involving nodule’s entire circumference. Nodule underwent resection, revealing oropharyngeal carcinoma metastasis. Case represents true-positive example of using ringlike peripheral high iodine concentration for diagnosis of pulmonary metastasis.


January 11, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), ringlike peripheral high iodine concentration maps from dual-energy CT (DECT) can help guide management in patients with known lung cancer and an indeterminate solitary nodule.

“Ringlike peripheral high iodine concentration had excellent interobserver agreement, showed high specificity (albeit poor sensitivity) for differentiating pulmonary metastasis from primary lung cancer, and independently predicted pulmonary metastasis,” wrote AJR first author Yoshinao Sato, MD, PhD, from the Diagnostic Imaging Center at Japan’s Cancer Institute Hospital in Tokyo.

This AJR accepted manuscript study included 93 patients (64 men, 29 women; median age, 70 years) who underwent resection of a primary lung cancer (n=68) or pulmonary metastasis (n=25) corresponding with a solid lesion on preoperative contrast-enhanced DECT performed between April 2020 and March 2021. After constructing venous-phase 120-keV single-energy images, equilibrium-phase 66-keV virtual monoenergetic images, as well as iodine concentration maps, two radiologists independently assessed lesions for the following: spiculated margins, air bronchograms, rim enhancement, and thin ringlike peripheral high iodine concentration.

Ultimately, ringlike peripheral high iodine concentration on DECT showed excellent interobserver agreement (κ=0.80), and had sensitivity of 52% and specificity of 81% for differentiating pulmonary metastases from primary lung cancers. Additionally, the finding independently predicted pulmonary metastasis in multivariate analysis [OR=7.81, 95% CI: 2.28–29.60; p=.001] combining patient and lesion characteristics.

“Iodine concentration maps from DECT could help determine the diagnosis for lesions that are equivocal for pulmonary metastasis on conventional images,” the authors of this AJR accepted manuscript reiterated.

For more information: www.arrs.org


Related Content

News | Teleradiology

April 1, 2026 — Premier Radiology Services has acquired Global Imaging Solutions (GLOBIS), a leading teleradiology group ...

Time April 03, 2026
arrow
News | Digital Pathology

March 29, 2026 — Leica Microsystems has introduced the Viventis SCAPE light sheet microscope. Viventis SCAPE enables ...

Time April 01, 2026
arrow
News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Time March 30, 2026
arrow
News | Digital Pathology

March 11, 2026 — Royal Philips has announced the expansion of its digital pathology portfolio with new cloud-enabled ...

Time March 26, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
News | Radiology Imaging

March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as ...

Time March 23, 2026
arrow
News | Radiology Business

March 1, 2026 — A new study from the Harvey L. Neiman Health Policy Institute found that practice turnover (i.e ...

Time March 19, 2026
arrow
News | Radiology Education

March 17, 2026 – The Center for Radiology Education (CRE) has announced a nationwide initiative to provide scholarships* ...

Time March 17, 2026
arrow
Subscribe Now